Trial Profile
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Musculoskeletal pain; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 03 Jan 2013 Planned number of patients changed from 160 to 240 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.